Update on cystic fibrosis: Selected aspects related to lung transplantation

Swiss Medical Weekly

Volumn 133, Issue 7-8, 2003, Pages 111-117

  Boehler, Annette ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Aspergillus; Burkholderia cepacia complex; Cystic fibrosis; Lung transplantation; Pseudomonas aeruginosa

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCINEURIN INHIBITOR; CALCIUM; CORTICOSTEROID; VITAMIN D;

ARTIFICIAL VENTILATION; ASPERGILLUS; ATYPICAL MYCOBACTERIUM; BACTERIAL COLONIZATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DIET THERAPY; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HUMAN; LIVER DISEASE; LIVING DONOR; LUNG TRANSPLANTATION; OSTEOPOROSIS; PATIENT REFERRAL; PATIENT SELECTION; PEROPERATIVE CARE; PREOPERATIVE EVALUATION; PSEUDOMONAS AERUGINOSA; REVIEW; SOCIAL ASPECT; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE;

EID: 0037460616     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation 1998;66:951-6.
2. Kerem E, Reisman J, Corey M, Canny G, Levison H. Prediction of mortality in patients with cystic fibrosis [see comments]. N Engl J Med 1992;326:1187-91.
3. Liou TG, Adler FR, FitzSimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001;153:345-52.
4. Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001;286:2683-9.
5. Venuta F, Rendina EA, Della Rocca G, Pugliese F, Ciccone AM, Vizza CD, et al. Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis. J Thorac Cardiovasc Surg 2000;119:682-9.
6. Stanchina ML, Tantisira KG, Aquino SL, Wain JC, Ginns LC. Association of lung perfusion disparity and mortality in patients with cystic fibrosis awaiting lung transplantation. J Heart Lung Transplant 2002;21:217-25.
7. LiPuma JJ. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl Infect Dis 2001; 3:149-60.
8. Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 1998:27:S93-S99.
9. Chiesa C, Labrozzi PH, Aronoff SC. Decreased baseline betalactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis. Pediatr Res 1986;20:1174-7.
10. Burns JL. Treatment of cepacia: in search of the magic bullet. Pediatr Pulmonol 1997;Suppl 14:90.
11. BurnsJL, Wadsworth CD, BarryJJ, Goodall CP. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother 1996;40:307-13.
12. Goldstein R, Sun L, Jiang RZ, Sajjan U, Forstner JF, Campanelli C. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol 1995;177:1039-52.
13. Sajjan US, Sun L, Goldstein R, Forstner JE Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 1995;177:1030-8.
14. Snell GI, deHoyos A, Krajden M, Winton T, Maurer J. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993;103:466-71.
15. Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med 1994;149:1601-7.
16. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 1997;47: 1188-200.
17. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burhholderia cepacia complex. AmJ Respir Crit Care Med 2001;164:2102-6.
18. Taylor CJ, Howden R, Smith T, Spencer RC. Pseudomonas cepacia. Arch Dis Child 1994;70:358.
19. De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001;358:1780-1.
20. Chaparro C, Maurer J, Gutierrez C, Krajden M, Chan C, Winton T, et al. Infection with Burkholderia cepacia in cystic fibrosis. Outcome following lung transplantation. Am J Respir Crit Care Med 2001;163:43-8.
21. McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers. An analysis of 1051 recent sputum isolates. Chest 2000;117:1661-5.
22. Aris RM, Giligan PH, Neuringer IP, Gott KK, Rea J, Yankaskas JR. The effect of pan resistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997; 155:1699-704.
23. Saiman L, Mehar F, Niu WW, Neu HC, Shaw KJ, Miller G, et al. Antibiotic susceptibility of multiply resistant pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis 1996;23:532-7.
24. Paradowski LJ. Saprophytic fungal infections and lung transplantation revisited. J Heart Lung Transplant 1997;16:524-31.
25. Reichenspurner H, Gamberg P, Nitschke M, Valantine H, Hunt S, Oyer PE, et al. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant Proc 1997;29:627-8.
26. Ebert DL, Olivier KN. Nontuberculous mycobacteria in the setting of cystic fibrosis. In: Catanzaro A, Daley CL, eds. Clinics in Chest Medicine. Vol. 23. Philadelphia: Saunders Company, WB, 2002:655-63.
27. Aitken ML, Burke W, McDonald G, Wallis C, Ramsey B, Nolan C. Nontuberculous mycobacterial disease in adult CF patients. Chest 1993;103:1096-9.
28. KilbyJM, Gilligan PH, Yankaskas JR, Highsmith jun WE, Eduards LJ, Knowles MR. Nontuberculous mycobacteria in adult patients with CF. Chest 1992;102:70-5.
29. Torrens JK, Dawkins P, Conway SP, Moya E. Non-tuberculous mycobacteria in CF. Thorax 1998;53:182-5.
30. Olivier KN, Handler AJ, Lee JH, et al. Clinical impact of non-tuberculous mycobacteria on the course of CF lung disease: results of a multicenter, nested cohort study. Pediatr Pulm 2000;30:102-3.
31. Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. AmJ Respir Crit Care Med 1999;160:1611-6.
32. Milkiewicz P, Skiba G, Kelly D, Weller P, Bonser R, Gur U, et al. Transplantation for cystic fibrosis: outcome following early liver transplantation. J Gastroenterol Hepatol 2002;17:208-13.
33. Fischer S, Bennett LE, Strueber M, Waddell TK, Niedermeier J, Keshavjee S, et al. Outcome following simultaneous and sequential lung-liver transplantation: analysis of the ISHLT/UNOS joint thoracic registry. J Heart Lung Transplant 2002; 21:108.
34. Noble-Jamieson G, Barnes N, Jamieson n, Friend P, Caine R. Liver transplantation for hepatic cirrhosis in cystic fibrosis. J R Soc Med 1996;89:31-7.
35. CouetilJP, Houssin DP, Soubrane O, et al. Combined lung and liver transplantation in patients with cystic fibrosis: a 4 year experience. J Thorac Cardiovasc Surg 1995;110:1415-22.
36. Snell GI, Bennetts K, Bartolo J, Levvey B, Griffiths A, Williams T, et al. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. J Heart Lung Transplant 1998;17:1097-103.
37. Haworth CS, Webb K, Egan JJ, Selby PL, Hasleton PS, Bishop PW, et al. Bone histomorphometry in adult patients with cystic fibrosis. Chest 2000;118:434-9.
38. Donnovan DS, Papadopoulos A, Staron RB, Addesso V, Shulman L, McGregor C, et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. AmJ Respir Crit Care Med 1998;157:1892-9.
39. Tschopp O, Boehler A, Speich R, Weder W, Seifert B, Russi EW, et al. Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant 2002;2:167-72.
40. Aris RM, Lester GE, Renner JB, Winders A, Denene Blackwood A, Lark RK, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000;162:941-6.
41. Meyers BF, Lynch JP, Battafarano RJ, Guthrie TJ, Trulock EP, Cooper JD, et al. Lung transplantation is warranted for stable, ventilator-dependent recipients. Ann Thorac Surg 2000;70: 1675-8.
42. Granton JT, Kesten S. The acute effects of nasal positive pressure ventilation in patients with advanced cystic fibrosis. Chest 1998;113:1013-8.
43. Durst CL, Horn MV, MacLaughlin EF, Bowman CM, Starnes VA, Woo MS. Psychosocial responses of adolescent cystic fibrosis patients to lung transplantation. Pediatr Transplantation 2001;5:27-31.
44. Corris PA. Living lobar lung transplantation. Curr Opin Organ Transplant 2002;7:271-4.
45. Starnes VA, Woo MS, MacLaughlin EF, Horn MV, Wong PC, Rowland JM, et al. Comparison of outcomes between living donor and cadaveric lung transplantation in children. Ann Thorac Surg 1999;68:2279-83.
46. Battafarano RJ, Anderson RC, Meyers BF, Guthrie TJ, Schuller D, Cooper JD, et al. Perioperative complications after living donor lobectomy. J Thorac Cardiovasc Surg 2000;120:909-15.
47. Mauron A, Chevrolet JC. Lung transplantation from living donors: ethical questions. Rev Mal Respir 2002;19:279-81.
48. Hodson ME. Transplantation using lung lobes from living donors. J Med Ethics 2000;26:419-21.
49. Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002;21:226-32.
50. Limbos MM, Joyce DP, Chan CKN, Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest 2000;118:408-16.
51. TenVergert EM, Essink-Bot ML, Geertsma A, van Enckevort PJ, de Boer WJ, van der Bij W. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest 1998;113:358-64.
52. Cohen L, Littlefield C, Kelly P, Maurer J, Abbey S. Predictors of quality of life and adjustment after lung transplantation. Chest 1998;113:633-44.